---
title: "Varex Imaging Corporation (VREX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/VREX.US.md"
symbol: "VREX.US"
name: "Varex Imaging Corporation"
industry: "Health Care Equipment"
---

# Varex Imaging Corporation (VREX.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Location | US Market |
| Website | [www.vareximaging.com](https://www.vareximaging.com) |

## Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionizatio...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:14.000Z

**Overall: C (0.58)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 65 / 185 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 4.09% |  |
| Net Profit YoY | -39.30% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.21 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 576.39M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 854.40M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -13.31% | D |
| Profit Margin | -7.92% | D |
| Gross Margin | 33.30% | C |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 4.09% | C |
| Net Profit YoY | -39.30% | D |
| Total Assets YoY | -17.58% | E |
| Net Assets YoY | -11.44% | D |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -1262.04% | E |
| OCF YoY | 4.09% | C |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.70 | B |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 55.30% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Varex Imaging Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-13.31%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-7.92%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "33.30%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "4.09%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-39.30%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-17.58%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-11.44%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-1262.04%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "4.09%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.70",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "55.30%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Inspire Medical (US.INSP) | A | B | A | A | B | A |
| 02 | Delcath (US.DCTH) | C | A | A | A | A | A |
| 03 | Intuitive Surgical (US.ISRG) | A | B | C | A | B | B |
| 04 | Stryker (US.SYK) | A | B | C | C | B | B |
| 05 | Boston Scientific (US.BSX) | B | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -8.51 | 139/181 | - | - | - |
| PB | 1.21 | 31/181 | 1.09 | 1.00 | 0.60 |
| PS (TTM) | 0.67 | 23/181 | 0.63 | 0.58 | 0.40 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-12T05:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 3 | 60% |
| Overweight | 1 | 20% |
| Hold | 1 | 20% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 13.59 |
| Highest Target | 22.00 |
| Lowest Target | 12.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/VREX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/VREX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/VREX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.